
Source: businesswire | Published on: Thursday, 06 March 2025
DUBLIN--(BUSINESS WIRE)--The "Enterprise Tech Ecosystem Series: F. Hoffmann - La Roche Ltd 2024" report has been added to ResearchAndMarkets.com's offering.
The report provides insights into company's tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives.
F. Hoffmann-La Roche Ltd (Roche) is a healthcare company that develops drugs and diagnostics devices for treating diseases. It provides medicine and diagnostics for oncology, immunology, neuroscience, ophthalmology, infectious diseases, respiratory, and other areas.
The company also provides in-vitro diagnostics, tissue-based cancer diagnostics, and diabetes management solutions. The company offers its products and services to hospitals, commercial laboratories, healthcare professionals, researchers, and pharmacists. The company, along with its subsidiaries, has operations across the Americas, Europe, Asia, Africa, and Oceania.
The report provides information and insights into Roche's tech activities, including:
Reasons to Buy
Key Topics Covered:
A selection of companies mentioned in this report includes, but is not limited to:
For more information about this report visit https://www.researchandmarkets.com/r/1hw7ep
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.